Day: June 20, 2023

VANCOUVER, Canada, June 20, 2023 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce that it has closed the first tranche of its previously announced C$3,000,000 non-brokered private placement (the “Offering”) by issuing 17,000,000 units (the “Units”) at a price of C$0.10 per Unit, for gross proceeds of up to C$1,700,000. Each Unit consists of one Sonoro common share and one common share purchase warrant. Each warrant entitles the holder thereof to purchase one additional Sonoro common share for a period of two years from the closing of the private placement at an exercise price of C$0.15 per share. The net proceeds from the Offering will be used to fund the ongoing development of a proposed heap leach mining operation at the Company’s Cerro Caliche gold...

Expansion Plan Expansion PlanSYDNEY, Australia, June 20, 2023 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (together with its subsidiaries, “Iris Energy”, “the Company” or “the Group”), a leading owner and operator of institutional-grade, highly efficient Bitcoin mining data centers powered by 100% renewable energy, today announced its expansion plan to 9.1 EH/s and revitalization of its high-performance computing (“HPC”) data center strategy, and provided a limited recourse equipment financing update. Key HighlightsChildress Phase 1 (first 100MW): construction of remaining 80MW underway, targeting expansion of data center capacity from 5.6 EH/s to ~9.1 EH/s1 by early 20242 Childress Phase 2 (second 100MW): long-lead items ordered to unlock ~13.6 EH/s1 Near-term focus on data center construction, retaining flexibility...

‘The Skulleton’ will Feature Two-time Oscar nominee Bruce Dern (The Hateful Eight), Tyrese Gibson (Fast & Furious franchise), Shawnee Smith (Saw franchise), and Taryn Manning (Orange is the New Black) Fairfield, CA., June 20, 2023 (GLOBE NEWSWIRE) — MetaWorks Platforms, Inc. (“MetaWorks” or the “Company”), (CSE: MWRK and OTCQB: MWRK), an award-winning Web3 company that owns and operates blockchain platforms in the entertainment technology space, announced today it has agreed to acquire the Web3 rights for the upcoming horror film ‘The Skulleton.’ This agreement provides MetaWorks exclusive access to images, videos, behind-the-scenes footage, and outtakes from the movie and the ability to create engaging NFTs for enthusiasts to enhance their connection to the film. Furthermore, MetaWorks has obtained Web3 rights,...

You are hereby invited to attend the Extraordinary General Meeting of Havila Kystruten AS.DATE: 27 JUNE 2023HRS: 09:00PLACE: Online (without physical attendance for shareholders)The translation into English has been provided for information purposes only.PROPOSAL FOR THE AGENDA:1. Opening of the meeting by the Chairman of the Board and a list of attending shareholders2. Election of chairperson and co-signatory of the minutes3. Approval of the notice and proposal for the agenda4. Increase in the Company’s share capital by way of cash contribution5. Increase in the Company’s share capital by way of set off6. Authorisation to carry out subsequent offering The notice will be sent to shareholders, by post to the registered address in VPS, or through VPS.The notice with attachments will be made available at the company’s homepage. Contacts: CEO...

KUALA LUMPUR, Malaysia, June 20, 2023 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) announced it has been appointed by Cogia GmbH as the latter’s distributor for the promotion and sale of its communication application known as “Socializer Messenger”. The “Socializer Messenger” is a game changing, complete communication suite. On top of the basic conventional services being offered by other messaging devices, this AI-based, military grade messenger elevates communications to four additional dimensions namely privacy, security, business and administration. In short, it is a secured all-in-one communication tool with full data encryption and privacy protection. “Socializer Messenger” is owned and controlled by Cogia GmbH, a software company based in Germany, with extensive experience in software...

An Emerging Markets Sponsored Commentary ORLANDO, Fla., June 20, 2023 (GLOBE NEWSWIRE) — Anonymous Intelligence Company Inc. (CSE: ANON) (OTC: ANICF) (FRANKFURT: 1JI0)  is a leading, computational intelligence, decentralized network and data technology company, focused on leveraging its proprietary suite of AI & privacy enabled products to empower increased confidence in technology for consumers and business alike. Simply put, Anonymous Intelligence Company is pioneering a new era where robust AI platforms and assured privacy come together to empower and simplify your future. See the Company’s Investor Presentation here. Here are a few recent headlines from the Company: Anonymous Intelligence Company announces “Turminal.ai” a revolutionary privacy protected AI dashboard Anonymous Intelligence Company Signs LOI to Acquire Enterprise...

— Critical initial step toward US reimbursement — NEWTOWN, Pa., June 20, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that its Portable Neuromodulation Stimulator (PoNS®) device has been awarded Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) accreditation by The Compliance Team (TCT), which is authorized by the Centers for Medicare & Medicaid Services (CMS) to accredit all DMEPOS products and services. The accreditation certifies that Helius has established processes that conform to TCT’s Exemplary Provider® DMEPOS Quality Standards. “We are thrilled that PoNS has been awarded DMEPOS accreditation. Not...

Milestone payment triggered by first commercial sale of HEMGENIX® in U.S. by CSL Behring LEXINGTON, Mass. and AMSTERDAM, June 20, 2023 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, announced the achievement of a $100 million milestone associated with the first commercial sale of HEMGENIX® in the United States by its partner, global biotechnology leader CSL (ASX: CSL). HEMGENIX® (etranacogene dezaparvovec) is a one-time administered gene therapy for the treatment of adults with hemophilia B who currently use factor IX prophylaxis therapy, or have current or historical life-threatening hemorrhage or have repeated, serious spontaneous bleeding episodes. “The first commercial sale in the U.S. is a major milestone for uniQure...